申请人:Cancer Targeted Technology LLC
公开号:US11225496B2
公开(公告)日:2022-01-18
Provided herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. Also provided are compositions including a compound of Formula (I) together with a pharmaceutically acceptable carrier, and methods for imaging prostate cancer cells.
本文提供了式(I)化合物或其药学上可接受的盐。还提供了包括式(I)化合物和药学上可接受的载体的组合物,以及前列腺癌细胞成像的方法。